• 1
    Tang WH, Yeo PS. Epidemiology of anemia in heart failure. Heart Fail Clin2010;6:271278.
  • 2
    Tang WH, Tong W, Jain A, et al.Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol2008;51:569576.
  • 3
    Komajda M, Anker SD, Charlesworth A, et al.The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. Eur Heart J2006;27:14401446.
  • 4
    Okonko DO, Mandal AKJ, Missouris CG, Poole-Wilson PA. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival. J Am Coll Cardiol2011;58:12411251.
  • 5
    Jankowska EA, Rozentryt P, Witkowska A, et al.Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J. 2010;31:18721880.
  • 6
    Anker SD, Comin Colet J, Filippatos G, et al.Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med2009;361:24362448.
  • 7
    van Veldhuisen DJ, Anker SD, Ponikowski P, Macdougall IC. Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches. Nat Rev Cardiol. 2011;31:485493.
  • 8
    Bovy C, Gothot A, Delanaye P, et al.Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrol Dial Transplant2007;22:11561162.
  • 9
    Naghii MR, Fouladi AI. Correct assessment of iron depletion and iron deficiency anemia. Nutr Health2006;18:133139.
  • 10
    Allen LA, Felker GM, Mehra MR, et al.Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail2010;16:230238.
  • 11
    Felker GM, Allen LA, Pocock SJ, et al.Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol2007;50:4047.
  • 12
    Uchida T. Change in red blood cell distribution width with iron deficiency. Clin Lab Haematol1989;11:117121.
  • 13
    Troughton RW, Prior DL, Frampton CM, et al.Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study). Am J Cardiol2005;96:257262.
  • 14
    Tang WH, Van Lente F, Shrestha K, et al.Impact of myocardial function on cystatin C measurements in chronic systolic heart failure. J Card Fail.2008;14:394399.
  • 15
    Tang WH, Tong W, Troughton RW, et al.Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure. J Am Coll Cardiol2007;49:23642370.
  • 16
    Tang WH, Shrestha K, Van Lente F, et al.Usefulness of C-reactive protein and left ventricular diastolic performance for prognosis in patients with left ventricular systolic heart failure. Am J Cardiol2008;101:370373.
  • 17
    Okonko DO, Marley SB, Anker SD, Poole-Wilson PA, Gordon MY. Erythropoietin resistance contributes to anaemia in chronic heart failure and relates to aberrant JAK-STAT signal transduction. Int J Cardiol.2011: Doi:10.1016/j.ij-card.2011.1007.1045.